Dexamethasone Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

ASH 2015: Eloquent-2 Update
Eloquent-2 Update: A Phase 3, Randomized, Open-Label Study of Elotuzumab in Combination with Lenalidomide/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma - 3-Year Safety and Effica... Author: InternationalMyelomaFoundation Added: 12/08/2015 (Source: Oncology Tube)
Source: Oncology Tube - December 8, 2015 Category: Cancer & Oncology Source Type: podcasts

ASCO 2014: Preliminary safety and efficacy of TH-302
Paul Richardson, MD Dana-Farber Cancer Institute Boston, Massachusetts, USA Preliminary safety and efficacy of TH-302, an investigational hypoxia-targeted drug, and dexamethasone (dex) in patient... Author: InternationalMyelomaFoundation Added: 09/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 11, 2015 Category: Cancer & Oncology Source Type: podcasts

ASCO 2014: MM-014 A phase 2 trial evaluating efficacy, safety, and biomarkers of POM+LoDEX in RRMM
David Siegel, MD John Theurer Cancer Center Hackensack, New Jersey, USA MM-014: A phase 2 trial evaluating efficacy, safety, and biomarkers of pomalidomide plus low-dose dexamethasone (POM + LoDE... Author: InternationalMyelomaFoundation Added: 09/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 11, 2015 Category: Cancer & Oncology Source Type: podcasts

ASCO 2014: A phase 1 trial of MK-3475 combined with Len and Lo-dose Dex in patients with RRMM
David Siegel, MD John Theurer Cancer Center Hackensack, New Jersey, USA A phase 1 (Ph1) trial of MK-3475 combined with lenalidomide (Len) and low-dose dexamethasone (Dex) in patients (pts) with r... Author: InternationalMyelomaFoundation Added: 09/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 11, 2015 Category: Cancer & Oncology Source Type: podcasts

ASCO 2014: A phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in RRMM
David Siegel, MD John Theurer Cancer Center Hackensack, New Jersey, USA A phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone (QUAD) in relapsed and/or refractory multiple m... Author: InternationalMyelomaFoundation Added: 09/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 11, 2015 Category: Cancer & Oncology Source Type: podcasts

ASCO 2014: Panorama 1 Phase 3 study of PAN or placebo plus BTZ and Dex in RRMM
Paul Richardson, MD Dana-Farber Cancer Institute Boston, Massachusetts, USA Panorama 1: A randomized, double-blind, phase 3 study of panobinostat or placebo plus bortezomib and dexamethasone in r... Author: InternationalMyelomaFoundation Added: 09/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 11, 2015 Category: Cancer & Oncology Source Type: podcasts

ASCO 2014: MM-005 Phase 1 trial of POM, BORT, and LoDEX in LEN refractory and PI exposed myeloma
Paul Richardson, MD Dana-Farber Cancer Institute Boston, Massachusetts, USA MM-005: Phase 1 trial of pomalidomide (POM), bortezomib (BORT), and low-dose dexamethasone (LoDEX [PVD]) in lenalidomid... Author: InternationalMyelomaFoundation Added: 09/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 11, 2015 Category: Cancer & Oncology Source Type: podcasts

ASCO 2014: Overall survival results of MM-003 after adjustment for crossover
Charlotte Pawlyn, MD Institute of Cancer Research Sutton, United Kingdom Pomalidomide plus low-dose dexamethasone (POM plus LoDEX) versus high-dose dexamethasone (HiDEX) for relapsed or refractor... Author: InternationalMyelomaFoundation Added: 09/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 11, 2015 Category: Cancer & Oncology Source Type: podcasts

ASCO 2014: A phase Ib dose escalation trial of SAR650984 in combination with len/dex in RR MM
Thomas G. Martin, MD University of California SF San Francisco, California, USA A phase Ib dose escalation trial of SAR650984 (Anti-CD-38 mAb) in combination with lenalidomide and dexamethasone i... Author: InternationalMyelomaFoundation Added: 09/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 10, 2015 Category: Cancer & Oncology Source Type: podcasts

Is the combination of Kyprolis, Cytoxan and dexamethasone available as a treatment?
Visit our website at: http://www.myeloma.org... Find us online: Facebook: http://facebook.com/myeloma... Google+: http://gplus.to/imfmyeloma... IMF on twitter: @IMFMyeloma (http://twitter.com/imfmyelo...)... Author: MultipleMyeloma Added: 09/02/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 2, 2015 Category: Cancer & Oncology Source Type: podcasts

ELOQUENT-2: Lenalidomide and dexamethasone with or without elotuzumab in relapsed/refractory multiple myeloma | Dr Joseph Mikhael at ASCO 2015
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Joseph R. Mikhael, MD, of Mayo Clinic, Scottsdale, AZ, discusses the results of the phase 3 ELOQUENT-2 trial of lenalidomide an... Author: EMJ Added: 07/20/2015 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2015 Category: Cancer & Oncology Source Type: podcasts

ASCO 2015: Results of the ELOQUENT-2 trial of elotuzumab in multiple myeloma
At ASCO 2015, Dr Joseph Mikhael discusses the results of ELOQUENT-2, a phase 3, randomized, open-label trial of lenalidomide plus dexamethasone with or without elotuzumab in patients with relapsed or ... Author: VJHemOnc Added: 07/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - July 10, 2015 Category: Cancer & Oncology Source Type: podcasts

FIRST study: Continuous lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma
At the 20th Congress of the European Hematology Association (EHA), Thierry Facon, MD, of the University Hospital Hurriez, Lille, France, discusses the updated overall survival analysis of the FIRST st... Author: VJHemOnc Added: 07/01/2015 (Source: Oncology Tube)
Source: Oncology Tube - July 1, 2015 Category: Cancer & Oncology Source Type: podcasts